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Abstract
Background: In the absence of well-equipped laboratory infrastructure in many developing countries the accurate
diagnosis of typhoid fever is challenging. Rapid diagnostic tests (RDT) with good performance indicators would be helpful
to improve clinical management of suspected cases. We performed a systematic literature review and meta- analysis to
determine the performance of TUBEX TF and Typhidot for the diagnosis of typhoid fever using PRISMA guidelines.
Methods: Titles and abstracts were reviewed for relevance. Articles were screened for language, reference method and
completeness. Studies were categorized according to control groups used. Meta-analysis was performed only for categories
where enough data was available to combine sensitivity and specificity estimates. Sub-analysis was performed for the
Typhidot test to determine the influence of indeterminate results on test performance.
Results: A total of seven studies per test were included. The sensitivity of TUBEX TF ranged between 56% and 95%,
Specificity between 72% and 95%. Meta-analysis showed an average sensitivity of 69% (95%CI: 45–85) and an average
specificity of 88% (CI95%:83–91). A formal meta-analysis for Typhidot was not possible due to limited data available. Across
the extracted studies, sensitivity and specificity estimates ranged from 56% to 84% and 31% to 97% respectively.
Conclusion: The observed performance does not support the use of either rapid diagnostic test exclusively as the basis for
diagnosis and treatment. There is a need to develop an RDT for typhoid fever that has a performance level comparable to
malaria RDTs.
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Introduction
Salmonella enterica serovar Typhi (Salmonella Typhi), the causative
agent of typhoid fever, has been estimated to have caused more
than 21.000.000 episodes of typhoid fever at a 1% mortality rate in
the year 2000 [1]. The major disease burden lies in developing
countries.
Due to the lack of reliable diagnostic tools the estimated
incidence rate may be an underestimate for the African continent,
as more recent data indicate [2,3]. Since typhoid fever has a non-
specific clinical picture [4,5], accurate diagnosis remains a
challenge in resource poor settings [6]. Blood culture is the
current reference method for diagnosis, however results are only
available after .48 hours, the procedure is expensive and requires
extensive laboratory equipment and technical expertise. Sensitivity
is estimated to be between 40% and 70% [7,8,9,10,11,12]. Culture
from bone marrow is known to be more sensitive [8,9,10],
however the invasive character renders the procedure inappro-
priate for large scale application. Rapid diagnostic tests (RDTs)
with good performance indicators at a low price are therefore
desirable to provide a reliable diagnosis.
Typhidot (Malaysian Biodiagnostic Research, Malaysia) and
Tubex TF (IDL, Sweden) are among the most widely used RDTs
within the more recently developed diagnostic devices for typhoid
fever. There are a number of other test available such as
the Typhidot-M (Malaysian Biodiagnostic Research, Malaysia),
the Multi-Test Dip-S-Ticks (Panbio INDX, US), SD Bioline
(Standard Diagnostics, Korea) and Mega Salmonella (Mega
Diagnostics, US) however little data on their performance is
available [13,14,15,16].
Tubex TF is based on an inhibition reaction between patient
antibodies (IgM) and monoclonal antibodies included in the test
that bind to a Salmonella Typhi specific O9 lipopolysaccharide.
A macroscopically visible de-colorization of patient serum in
test reagent solution through magnetic particle separation
indicates a positive result. In contrast the Typhidot is based on
a qualitative dot-blot enzyme-linked immunosorbent assay
that separately detects the presence of IgM and IgG in patient
sera against a Salmonella Typhi specific 50 kD outer membrane
protein.
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Several studies have assessed the performance of either test for
the diagnosis of symptomatic patients, but no formal meta-analysis
of the available data has been performed to date.
We therefore aimed to analyze the diagnostic performance of
Tubex TF (IDL, Sweden) and Typhidot (Malaysian Biodiagnostic
Research, Malaysia) for the diagnosis of typhoid fever in patients
in typhoid endemic regions.
Methods
General
We performed a review and meta- analyses using the PRISMA
guidelines [17] for systematic reviews and meta-analyses (Checklist
S1).
Search method and inclusion criteria
We performed a literature search in the MEDLINE database
through PubMed using ‘‘Tubex’’ and ‘‘Typhidot’’ as search terms.
Searches were restricted to publications from 1998 to date to cover
the time since introduction of either test to the market. In addition
we conducted supplementary searches in the references of the
retrieved articles. Titles and abstracts were reviewed for relevance.
Only articles evaluating the performance of one of the two or
both test were included. Articles were excluded based on title,
abstract, language other than English, lack of automated blood
culture as reference method assuming that automated blood
culture has a better yield in patients with previous antimicrobial
treatment and to assure standardization across the different studies
[18]. Articles were further excluded because presented data was
insufficient and authors did not reply to our queries. Whenever
automated and manual blood culture had been used as reference
method, only results of the automated blood culture were
included. Corresponding authors were contacted via email for
additional information whenever necessary. Information provided
by the authors was anonymized. If no answer was provided within
eight weeks of the first email and two additional follow up
emails (sent without an error report) the respective studies were
excluded.
Data retrieval and definitions
The number of true positives (TF), true negatives (TN), false
positives (FP) and false negatives (FN) were retrieved from each
article by two investigators independently and entered into an
excel datasheet. Discordant findings were assessed in a joint
approach and authors asked for verification when in doubt. We
obtained sensitivity, specificity and accuracy estimates of each
included study considering blood culture as the reference method.
Sensitivity was defined as the number of true positive results per
true positive and false negative results
TP
TPzFN
 
. Specificity
was defined as the number of true negative results per true
negative and false positive results
TN
TNzFP
 
. Accuracy was
defined as the number of true results divided by the total sample
size
TPzTN
TPzTNzFPzFN
 
.
To address poor sensitivity of blood culture [7,8,9,10,11,12] we
repeated the analysis applying different control groups whenever
possible. Control groups to determine true negatives were defined
as follows: category 1 – samples with known etiology other than
Salmonella Typhi; category 2 – samples with unknown etiology
(blood culture negative); category 3 – categories 1 and 2 combined.
Results for IgM and IgG for the Typhidot where assessed
separately. Whenever articles evaluating the Typhidot did not
present results for IgG and IgM separately, authors were contacted
and asked to provide respective data. Based on these data
the following outcomes were defined: presence of IgM alone= -
positive (diseased); presence of both IgG and IgM=positive;
absence of both IgG and IgM=negative; presence of IgG
alone = indeterminate. If information regarding the number of
indeterminate results among cases and controls was not provided
in the article the respective numbers were retrieved from the
authors.
Risk of bias
The QUADAS checklist [19] has been completed for all
included studies (Table S1). Given the limited number of studies
included, we did not perform a sensitivity analyses excluding lower
quality studies. However sensitivity analyses for the most likely
source of bias, the handling of indeterminate results has been
performed as described below.
Tubex TF
For Tubex TF we plotted estimates of the sensitivity and
specificity in forest plots as well as receiver-operating characteristic
(ROC) space using RevMan 5 [20] for each category. Meta-
analysis was performed only for categories where enough data was
available to produce average sensitivity and specificity
estimates. Estimates were calculated using logistic regression
separately for sensitivity and specificity correcting for heterogenity
among studies using robust standard errors (generalized estimating
equations), an approach similar to random effects meta-analysis
[21].
Typhidot
For Typhidot no formal meta-analysis was performed, firstly
due to the low number of studies included in each control group
and secondly because information on the inclusion or exclusion of
indeterminate results could not be retrieved for all studies. For
studies where information on the number of indeterminate results
was available, sensitivity, specificity and accuracy estimates were
calculated using three different approaches:
Firstly we excluded the indeterminate results completely from
the analyses, Secondly we defined the indeterminate results as
negative results (TN and FN respectively):
Sensitivity~
TP
TPzFNzIndeterminate cases
Specificity~
TNzIndeterminate controls
TNzFPzIndeterminate controls
Thirdly we added indeterminate results only to the denominator,
resulting in a new formula for specificity only but not for sensitivity
when compared to the second approach:
Specificity~
TN
TNzFPzIndeterminate controls
For studies where information on the number of indeterminate
results was not available the results are presented as given by the
respective authors.
Review and Meta-Analyses of TUBEX TF and Typhidot
PLOS ONE | www.plosone.org 2 December 2013 | Volume 8 | Issue 12 | e81263
95% Confidence intervals were calculated according to Wilsons
score method and the difference between accuracy estimates was
calculated using chi2 test considering p,0.05 as significant.
Results
The search word ‘‘Tubex’’ retrieved 23 hits, ‘‘Typhidot’’
retrieved 24 hits. Based on the title we excluded two articles
(8.7%) for the evaluation of the Tubex TF test and three (12.5%)
for the Typhidot. For Tubex TF nine articles (39.1%) and for
Typhidot three (12.5%) were excluded based on the abstract.
Respectively five (17.4%) [22,23,24,25,26] and 11 (45.8%)
[24,26,27,28,29,30,31,32,33,34] studies were excluded as the
underlying methods did not fit our predefined criteria (Figure 1).
The QUADAS checklist revealed that risk of bias could generally
be considered low for all studies (Table S1).
Tubex TF
A total of seven (30.4%) studies evaluating Tubex TF with
different control groups were included in the analyses. One of the
studies used two different control groups as comparison and was
therefore included in two different categories [35] with the
respective results. A total of five studies using febrile controls with
known etiology [13,29,31,35,36] were therefore included in
category 1, two studies using controls with unknown febrile
diseases [15,35] were included in category 2 and one study that
used controls with known and unknown etiology [37] was included
in category 3. Characteristics of the studies are summarized in
Table 1.
Sensitivity of Tubex TF in the studies included in category 1
varied between 56% [29] and 79% [36], specificity between 85%
[35] and 95% [31]. Sensitivity and specificity for studies
included in category 2 were 75% [35] and 95% [15] and
88% [35] and 80% [15] respectively and the study in category
3 showed sensitivity of 68% and specificity of 72% [37]
(Figure 2).
Meta-analysis of the data in category 1 showed an
average sensitivity of 69% (95%CI: 45–85) and a specificity of
88% (CI95%:83–91)(Figure 3). No meta-analysis was performed
for the other categories due to the low number of studies
included.
Typhidot
For the evaluation of the Typhidot a total of seven (29.2%)
studies were included in the analyses. Two studies used two
different control groups and were therefore included in two
categories with the respective results [14,35]. Therefore a total of
three studies could be included in category 1 [13,14,35], four
studies in category 2 [14,15,35,38] and two studies in category 3
[37,39]. Additional characteristics of the included studies are
shown in Table 2.
The number of indeterminate results (presence of IgG alone)
obtained when using Typhidot showed a great variation among
studies. Kawano et al. [15] reported 55 indeterminate results (out
of 366 total results) both among cases and controls respectively.
Fadeel et al. [35] reported five indeterminate samples among cases
and one among controls (out of a total of 140 and 210 results
depending on the control group), Olsen et al. [13] reported six
indeterminate results, three among cases and three among controls
(out of a total of 77 results), Keddy et al. [37] reported no
indeterminate results (out of 80 results).
Depending on how indeterminate results are classified sensitivity
and specificity can vary. Highest numbers of indeterminate results
for the Typhidot were reported by Kawano et al [15] with a total of
30% of all results being indeterminate. Accordingly sensitivity of
the test was 82% when indeterminate results were excluded, 56%
when the respective results were considered negative and 56%
when indeterminate results were included in the denominator.
Accordingly specificity was 44%, 60% and 31% respectively
(p,0.05 for accuracy).
For studies with smaller numbers of indeterminate results
no significant differences in accuracy were found and
sensitivity varied between 63% and 84%, specificity between
74% and 97% depending on control group and definition of
indeterminate results (Table 3). Results from studies were no
information on indeterminate results were available are listed in
Table 4.
Discussion
Our meta-analysis for Tubex TF showed an average sensitivity
of 69% and a specificity of 88%. Even though no meta-analysis
was performed for the Typhidot, sensitivity and specificity varied
between 46% and 79% and 31% and 96% respectively when
including indeterminate results in the denominator only and across
all three control groups. The number of indeterminate results
varied between 0% [37] and 30% [15] of the entire study
population. However we found that apart from the study
conducted by Kawano et al. [15] the number of indeterminate
results was low and did not significantly affect test accuracy
(p.0.05) (Table 3). This study only considered sensitivity,
specificity, and accuracy for analysis but not predictive
values. Predictive values are much heavier affected by prevalence
of disease within the study population than sensitivity and
specificity, making it difficult to compare predictive values of
different studies.
Malaria and typhoid fever may be considered among the
most mportant non-viral infectious diseases in developing
countries. For malaria a plethora of RDTs is available and
current WHO recommendations for the use of those RDTs as
an exclusive method of diagnosis postulate a specificity .90%
in order to be used on a wider scale [40]. While the average
performance of the Tubex TF does not qualify according to
these criteria, few individual studies for Tubex TF [29,31]
and Typhidot [35,39] report performance above the given
threshold.
Since typhoid fever is a potentially fatal disease, easily treatable
with affordable antibiotics, its treatment threshold is very low.
Moreover no clinical signs with sufficient predictive value are
available, and consequently in most situations the disease is treated
presumptively. In order for a typhoid RDT to be superior to
presumptive treatment, a respective test would require a high
sensitivity, in order not to miss possibly fatal cases. On the other
hand, even a moderate specificity will allow avoiding the many
false positives inherent to the presumptive strategy, leading to
unnecessary antibiotics overuse, resulting in resistance on a
population scale. The question remains, if RDT’s based on
antibodies are sufficiently sensitive for an early presentation.
Malaria tests are based on antigen detection, an approach that
yields positive results earlier after infection, as the result is not
delayed by a host immunological response.
Parry et al. [41] suggest testing paired samples to improve
performance of the RDTs. Assuming that false positive results
occur on an independent basis, this will increase specificity.
Likewise, if samples are taken at a timely interval this is likely to
improve sensitivity due to higher antibody titers within the course
of the disease. The latter approach might be useful for
Review and Meta-Analyses of TUBEX TF and Typhidot
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Figure 1. Selection of studies included in the analyses.
doi:10.1371/journal.pone.0081263.g001
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epidemiological purposes but its value in a clinical setting is
limited.
The major limitation of the presented data is the small
number of study results available. While sufficient publications
were retrieved to calculate performance indicators for the
Tubex TF test, this was not possible for Typhidot. Different
methods in defining and including controls have made it
difficult to standardize earlier collected data and have
further reduced the number of data that we could compare
directly.
The unknown sensitivity of blood culture is likely to have
affected the analyzed results. We excluded all studies where
manual blood culture was used as a reference method, assuming
that automated blood culture has a higher yield in patients with
previous antibiotic treatment and to assure some standardization
of the workflow across the different studies included [18]. However
also automated blood culture results are dependent on skills and
knowledge of the performing laboratory staff as well as the
condition of local laboratory equipment and consumables.
Moreover choosing the most appropriate control group for an
RDT evaluation remains a challenge when blood culture is the
reference method. Including blood culture negative patients in the
control group bears the risk of including undetected Salmonella
Typhi cases due to poor sensitivity of blood culture among the
controls affecting the specificity of the evaluated test. On the other
hand including only febrile cases with a confirmed laboratory
diagnosis other than typhoid fever results in an unrealistic control
group.
Additional limitations in the longitudinal test evaluation are
inter-batch variation as well as minor test modification by the
manufactures that are not leading to changes in the brand name
and not made public [42,43]. Indeed the Tubex TF test had been
modified within the evaluated time period without changes of the
product name (IDL personal communication). The study
Table 1. Characteristics of included studies.
Study
Test evaluated (Typhidot/
Tubex)
Control group
used*
Additional data received from
the authors (Yes/No) Country
Dong et al, 2008 [31] Tubex 1 No Southern China
Dutta et al, 2006 [29] Tubex 1 No Calcutta, India
Fadeel et al, 2011 [35] Typhidot/Tubex 1; 2 Yes Egypt
Gopolaskrishnan et al, 2002 [14] Typhidot 1; 2 Yes Kuala Lumpur, Malaysia
Jesudason et al, 2002 [38] Typhidot 2 Yes Vellore, India
Jesudason et al, 2006 [39] Typhidot 3 Yes Vellore, India
Kawano et al, 2007 [15] Typhidot/Tubex 2 Yes Philippines
Keddy et al, 2011 [37] Typhidot/Tubex 3 Yes South Africa/Tanzania
Ley et al, 2011 [36] Tubex 1 No Tanzania
Olsen et al, 2004 [13] Typhidot/Tubex 1 Yes Ho Chi Min city, Vietnam
*controls groups: 1 – samples with known etiology other than Salmonella Typhi; 2 – samples with unknown etiology (blood culture negative); 3 – a combination of 1
and 2.
doi:10.1371/journal.pone.0081263.t001
Figure 2. Forest Plot for Tubex TF with different control groups.
doi:10.1371/journal.pone.0081263.g002
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from Olsen et al [13] had evaluated the former version of the test
(IDL personal communication), however when repeating
the analysis and excluding the respective publication, we found
similar results for average sensitivity and specificity (data not
shown).
In the light of poor sensitivity of current blood culture
procedures at high costs, requiring considerable expertise and
long time to diagnosis, the demand for a reliable RDT in clinical
settings remains high. Apart from good performance indicators, a
respective test would require good operational characteristics as
Figure 3. Sensitivity and specificity estimates for Tubex TF (open squares) with control group category 1 together with average
sensitivity and specificity estimate (filled circle) and 95% confidence region.
doi:10.1371/journal.pone.0081263.g003
Table 2. Overview Typhidot studies.
Comment
Typhidot with control group 1
Fadeel, 2011 -Results are originally presented for IgG and IgM separately. Additional data provided by the author.
Gopalakrishnan, 2002 -No information on the number of indeterminate results/not specified how they were counted.
Olsen, 2004 -Results are originally presented for 2 hospitals combined. We only included data using automated
blood culture as reference method as provided by the author.
Typhidot with control group 2
Fadeel, 2011 -Results are originally presented for IgG and IgM separately. Additional data provided by the author.
Gopalakrishnan, 2002 -No information on the number of indeterminate results/not specified how they were counted.
Jesudason, 2002 -No information on the number of indeterminate results/not specified how they were counted.
Kawano, 2007 -Results are originally presented for IgG and IgM separately. Additional data provided by the author.
Typhidot with control group 3
Jesudason, 2006 -No information on the number of indeterminate results/not specified how they were counted.
Keddy, 2011 -Additional data provided by author.
doi:10.1371/journal.pone.0081263.t002
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well as moderate pricing comparable to currently used malaria
RDTs. In addition a diagnostic device to detect Salmonella carriers
would be a powerful tool to estimate true disease burden and
potential of transmission [41].
Conclusion
The performance of Typhidot and TUBEX TF does not
support the use of either rapid diagnostic test exclusively as a basis
for diagnosis and treatment. Although more time consuming and
related to higher expenses and logistics, blood culture and
molecular biologic techniques remain the reference method of
choice, despite its limitations. There is a need to develop an RDT
for typhoid fever that has a performance level comparable to
malaria RDTs.
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